These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions. Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275 [TBL] [Abstract][Full Text] [Related]
3. Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series. Johnston MS; Galan A; Watsky KL; Little AJ JAMA Dermatol; 2021 Jun; 157(6):716-720. PubMed ID: 33978670 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159 [No Abstract] [Full Text] [Related]
6. Case series of chronic spontaneous urticaria following COVID-19 vaccines: an unusual skin manifestation. Ben-Fredj N; Chahed F; Ben-Fadhel N; Mansour K; Ben-Romdhane H; Mabrouk RSE; Chadli Z; Ghedira D; Belhadjali H; Chaabane A; Aouam K Eur J Clin Pharmacol; 2022 Dec; 78(12):1959-1964. PubMed ID: 36255482 [TBL] [Abstract][Full Text] [Related]
7. Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose. Gallagher MC; Haessler S; Pecoy-Whitcomb E; Bayuk J Allergy Asthma Proc; 2022 Jan; 43(1):37-39. PubMed ID: 34983708 [No Abstract] [Full Text] [Related]
8. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744 [TBL] [Abstract][Full Text] [Related]
10. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis. Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821 [TBL] [Abstract][Full Text] [Related]
12. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
13. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines. Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines. Wang CW; Chen CB; Lu CW; Chen WT; Hui RC; Chiu TM; Chi MH; Lin JC; Huang YH; Chang YC; Wu J; Chen KY; Lin YY; Ger TY; Lin JY; Tsai WT; Pan YJ; Chung WH J Autoimmun; 2023 Jul; 138():103054. PubMed ID: 37245259 [TBL] [Abstract][Full Text] [Related]
17. Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US. Hause AM; Zhang B; Yue X; Marquez P; Myers TR; Parker C; Gee J; Su J; Shimabukuro TT; Shay DK JAMA Netw Open; 2022 Jul; 5(7):e2222241. PubMed ID: 35838667 [TBL] [Abstract][Full Text] [Related]
18. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination. Weir C; Sung-In Jang H; Fernando SL Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718 [TBL] [Abstract][Full Text] [Related]
19. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862 [TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]